Zydus Cadila 3-dose COVID-19 Vaccine for Children may take Longer to be Approved
A vaccine against the coronavirus disease (Covid-19) for children being developed by Gujarat-based drug company Zydus Cadila may not be available soon as emergency approval from the country's top drug regulator is likely to take a few more days.
On July 1, the company had sought emergency use approval of ZyCoV-D, its DNA vaccine against Covid-19 for those aged 12 years and above, from the Drugs Controller General of India (DCGI).
It had presented interim results from Phase-III clinical trials in over 28,000 volunteers. The study is said to have demonstrated safety and efficacy in the interim data.
The data has shown that ZyCoV-D is safe for children in the age group of 12 to 18 years, said the company, which is planning to manufacture 100-120 million doses of the vaccine an...